News | April 25, 2023
Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Subscribe To Our Newsletter & Stay Updated
